Farfour Éric, Rouabah Lamia, Bargain Pauline, Lecuru Marion, Picard Clément, Tcherakian Colas, Maneglier Benjamin, Juillet Stéphanie Marque, Vasse Marc
Service de Biologie Clinique, Hôpital Foch, 40 rue Worth, 92150 Suresnes, France.
Service de Biologie Clinique, Hôpital André Mignot, Le Chesnay, France 177 rue de Versailles, 78150 Le Chesnay-Rocquencourt, France.
Ann Biol Clin (Paris). 2023 Oct 20;81(4):403-409. doi: 10.1684/abc.2023.1827.
SARS-CoV-2 has impacted the detection of seasonal respiratory viruses. We retrospectively assessed the trend in the detection of 10 viruses in the COVID-19 area in 2 hospitals located in the Paris area.
All patients positive for a respiratory virus in two hospitals from September 2016 to August 2021 were retrospectively included. The rate of RT-PCR positive for each virus was calculated for the 2020-2021 season and the 2019-2020 season in comparison to a baseline of 3 seasons, i.e. 2016-2017, 2017-2018, and 2018-2019.
Overall, 7,835 patients were tested positive from September 2016 to August 2021. The detection of respiratory virus dramatically falls on week-11 of 2020, as the number of RT-PCR performed. Then, 3 trends were identified: a) almost a disappearance for influenza; b) a 10-weeks delay in the seasonal outbreak for RSV; c) a persistence of circulation with variable activity for other viruses. In comparison to a baseline of three seasons (2016-2019), the rate of positive patients was lower during the 2020-2021 season for coronavirus (4.51% vs. 1.26%, P < 0.0001), adenovirus (1.93% vs. 1.34%, P = 0.14), bocavirus (0.58% vs. 0.11%, P = 0.08), and enterovirus (0.28% vs. 0.0%, P = 0.12). In contrast, the rate of hMPV-positive (1.92% vs. 2.83%, P = 0.03) and hPIV-positive (2.17% vs. 2.99%, P = 0.06) patients increased.
The fall in the number of respiratory viruses detected might be related to the lower number of tests performed and the implementation of non pharmaceutical intervention (NPI). Then, all viruses except influenza are detected, probably as a consequence of high adherence to influenza vaccines. Despite, a lower number of tests being performed, the rate of hMPV-positive and hPIV-positive patients increased suggesting an active circulation of these viruses. Altogether, these findings suggest a persistent circulation of common respiratory viruses all over the COVID-19 era.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对季节性呼吸道病毒的检测产生了影响。我们回顾性评估了位于巴黎地区的两家医院COVID-19区域内10种病毒的检测趋势。
回顾性纳入2016年9月至2021年8月期间两家医院呼吸道病毒检测呈阳性的所有患者。计算了2020 - 2021季节和2019 - 2020季节每种病毒的逆转录聚合酶链反应(RT-PCR)阳性率,并与三个季节(即2016 - 2017、2017 - 2018和2018 - 2019)的基线进行比较。
总体而言,2016年9月至2021年8月期间有7835名患者检测呈阳性。随着RT-PCR检测数量的增加,呼吸道病毒的检测在2020年第11周急剧下降。然后,确定了三种趋势:a)流感几乎消失;b)呼吸道合胞病毒(RSV)季节性爆发延迟10周;c)其他病毒持续传播且活动程度各异。与三个季节(2016 - 2019年)的基线相比,2020 - 2021季节冠状病毒阳性患者的比例较低(4.51%对1.26%,P < 0.0001),腺病毒(1.93%对1.34%,P = 0.14),博卡病毒(0.58%对0.11%,P = 0.08)和肠道病毒(0.28%对0.0%,P = 0.12)。相比之下,人偏肺病毒(hMPV)阳性(1.92%对2.83%,P = 0.03)和人副流感病毒(hPIV)阳性(2.17%对2.99%,P = 0.06)患者的比例有所增加。
检测到的呼吸道病毒数量下降可能与检测次数减少以及非药物干预(NPI)的实施有关。然后,除流感外的所有病毒都被检测到,这可能是由于对流感疫苗的高接种率。尽管检测次数减少,但hMPV阳性和hPIV阳性患者的比例增加,表明这些病毒在活跃传播。总之,这些发现表明在整个COVID-19大流行期间常见呼吸道病毒持续传播。